{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:08:11Z","timestamp":1788836891484,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jdiacomp.2026.109394","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:13:37Z","timestamp":1787588017000},"page":"109394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between SGLT-2 inhibitor use and retinal microvascular parameters in patients with Type 2 diabetes mellitus: A cross-sectional study"],"prefix":"10.1016","volume":"40","author":[{"given":"Serap","family":"Castur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5174-4606","authenticated-orcid":false,"given":"Mehmet Umut","family":"Capar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-5418","authenticated-orcid":false,"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutfullah","family":"Castur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9853-969X","authenticated-orcid":false,"given":"Sevval","family":"Eksert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0661-5570","authenticated-orcid":false,"given":"Busenur","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-058X","authenticated-orcid":false,"given":"Taner","family":"Damci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-623X","authenticated-orcid":false,"given":"Mustafa Sait","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109394_bb0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/glycob\/cwx047","article-title":"Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy","volume":"27","author":"Wakisaka","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8867875","article-title":"The role of SGLT2 inhibitor on the treatment of diabetic retinopathy","volume":"2020","author":"Sha","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0015","article-title":"Comparing and contrasting the effects of the sglt inhibitors canagliflozin and empagliflozin on the progression of retinopathy","volume":"28","author":"Herat","year":"2023","journal-title":"FBL"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0025","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"Association AD","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0035","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.neo.7900071","article-title":"Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy","volume":"2","author":"Fujimoto","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","article-title":"Optical coherence tomography angiography","volume":"64","author":"Spaide","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajo.2015.04.021","article-title":"Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study","volume":"160","author":"Ishibazawa","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jdiacomp.2026.109394_bb0055","article-title":"Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy","volume":"1","author":"Virgili","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0060","first-page":"S61","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142026","volume":"49","author":"Diabetes* ADAPPCf","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219164","article-title":"Reduced vessel density in the superficial and deep plexuses in diabetic retinopathy is associated with structural changes in corresponding retinal layers","volume":"14","author":"Lavia","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/IAE.0000000000001990","article-title":"Early microvascular and neural changes in patients with type 1 and type 2 diabetes mellitus without clinical signs of diabetic retinopathy","volume":"39","author":"Vujosevic","year":"2019","journal-title":"RETINA"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1167\/iovs.61.10.53","article-title":"Vascular density of deep, intermediate and superficial vascular plexuses are differentially affected by diabetic retinopathy severity","volume":"61","author":"Ashraf","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40942-021-00347-z","article-title":"Early neurovascular retinal changes detected by swept-source oct in type 2 diabetes and association with diabetic kidney disease","volume":"7","author":"da Silva","year":"2021","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.63.6.4","article-title":"The ganglion cell-inner plexiform layer thickness\/vessel density of superficial vascular plexus ratio according to the progression of diabetic retinopathy","volume":"63","author":"Sung","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0090","article-title":"Dapagliflozin prevents nox- and SGLT2-dependent oxidative stress in lens cells exposed to fructose-induced diabetes mellitus","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0095","doi-asserted-by":"crossref","first-page":"e2348431","DOI":"10.1001\/jamanetworkopen.2023.48431","article-title":"Sodium-glucose cotransporter 2 inhibitors and risk of retinopathy in patients with type 2 diabetes","volume":"6","author":"Yen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00417-023-06273-0","article-title":"Sglt2 inhibitors and diabetic retinopathy progression","volume":"262","author":"Nadelmann","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0105","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11206051","article-title":"Physicians\u2019 considerations and practice recommendations regarding the use of sodium-glucose cotransporter-2 inhibitors","volume":"11","author":"Jabbour","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0115","series-title":"Classification of Diabetes Mellitus. Geneva","author":"World health organization","year":"2019"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0120","series-title":"tedavi ve izlem k\u0131lavuzu","author":"Temd diabetes mellitus ve komplikasyonlar\u0131n\u0131n tan\u0131","year":"2022"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0125","first-page":"S179","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes\u20142024","volume":"47","author":"Committee ADAPP","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Bmj"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0140","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0161-6420(98)93601-6","article-title":"Topography of diabetic macular edema with optical coherence tomography","volume":"105","author":"Hee","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00006982-200212000-00012","article-title":"Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (oct)","volume":"22","author":"Goebel","year":"2002","journal-title":"RETINA"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0155","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/IAE.0000000000000716","article-title":"Optical coherence tomography angiography features of diabetic retinopathy","volume":"35","author":"Hwang","year":"2015","journal-title":"RETINA"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0160","doi-asserted-by":"crossref","DOI":"10.2337\/db23-500-P","article-title":"500-p: Causal effect of SGLT2 inhibition on diabetes-related retinopathy (DR) and macular edema (DME)","volume":"72","author":"Stevens","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0165","first-page":"2169","article-title":"Sglt2 inhibitors and diabetic retinopathy progression","volume":"63","author":"Nadelmann","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0170","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jfo.2021.01.005","article-title":"Do sglt2 inhibitors prevent preclinical diabetic retinopathy? A prospective pilot optical coherence tomography angiography study","volume":"44","author":"Sabaner","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0175","article-title":"Optical coherence tomography angiography in diabetic patients: a systematic review","volume":"10","author":"Boned-Murillo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6807219","article-title":"Potent oral hypoglycemic agents for microvascular complication: sodium-glucose cotransporter 2 inhibitors for diabetic retinopathy","volume":"2018","author":"Cho","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0185","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4093\/dmj.2022.0221","article-title":"Risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists","volume":"47","author":"Lin","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0190","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.oret.2024.05.003","article-title":"Comparative effectiveness of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, dipeptidyl peptidase-4 inhibitors, and sulfonylureas for sight-threatening diabetic retinopathy","volume":"8","author":"Barkmeier","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0195","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s13300-024-01649-9","article-title":"Comparison of the risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus in Japan: a retrospective analysis of real-world data","volume":"15","author":"Koshizaka","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2026.109394_bb0200","doi-asserted-by":"crossref","first-page":"17049","DOI":"10.1038\/s41598-023-43893-2","article-title":"Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687272600139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687272600139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:29:03Z","timestamp":1788834543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687272600139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S105687272600139X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109394","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between SGLT-2 inhibitor use and retinal microvascular parameters in patients with Type 2 diabetes mellitus: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109394"}}